Results 21 to 30 of about 10,636 (185)

Excited Delirium and Sudden Death: A Syndromal Disorder at the Extreme End of the Neuropsychiatric Continuum [PDF]

open access: yes, 2016
Over the past decade, the excited delirium syndrome (ExDS) has raised continuous controversy regarding the cause and manner of death of some highly agitated persons who die in police custody, during physical restraint or incapacitation by electrical ...
Deborah C. Mash
core   +2 more sources

NEUROLEPTIC MALIGNANT SYNDROME [PDF]

open access: yesSouthern Medical Journal, 1990
Neuroleptic malignant syndrome is a life-threatening reaction of neuroleptic medication. The estimated incidence rate of neuroleptic malignant syndrome is between 1% and 1.5% of patients treated with neuroleptics. The reported mortality rate varies from 11% to 38%.
M S, Jahan, A I, Farooque, Z, Wahid
openaire   +4 more sources

Katatones Dilemma unter Kombinationsbehandlung mit Lithium und Risperidon [PDF]

open access: yes, 2010
OBJECTIVE: The case of a schizoaffective patient suffering from a malignant catatonic syndrome following combined lithium-risperidone therapy is explored. METHOD: A case report and relevant deliberations regarding pathophysiology of the catatonic dilemma
Böker, H   +3 more
core   +1 more source

Antidepressant induced hyponatremia: does it increase the risk of Neuroleptic Malignant Syndrome in elderly patient?

open access: yesPsychiatry and Behavioral Sciences, 2016
Neuroleptic malignant syndrome (NMS) is a rare, life-threatening idiosyncratic reaction secondary to antipsychotic medication. Hyponatremia frequently develops in elderly patients and also psychiatric patients and may associate with neuroleptic malignant
Bilge Burcak Annagur, Nursel Akbaba
doaj   +1 more source

Olanzapine-Induced Neuroleptic Malignant Syndrome

open access: yesIranian Journal of Medical Sciences, 2017
Neuroleptic malignant syndrome (NMS) is a rare but life-threatening idiosyncratic side effect resulting from neuroleptic drugs. NMS mainly occurs in patients treated with high-potency typical antipsychotics, but rarely caused by atypical antipsychotics ...
Seyedhamze Hosseini, Forouzan Elyasi
doaj   +3 more sources

Metoclopramide Neurological Side Effects Screening; A Pharmacovigilence Study in Romanian Community Pharmacies [PDF]

open access: yes, 2015
Background. Metoclopramide is a pharmacological agent frequently used in therapy against nausea and vomiting that can occur in indigestion, motion sickness, gastric ulcer, pyloric spasm and after surgery as a side effect of some anesthetics.
Junghină, Adrian   +4 more
core   +4 more sources

A rare case of neuroleptic malignant syndrome presenting with serious hyperthermia treated with a non-invasive cooling device: a case report

open access: yesJournal of Medical Case Reports, 2009
Introduction A rare side effect of antipsychotic medication is neuroleptic malignant syndrome, mainly characterized by hyperthermia, altered mental state, haemodynamic dysregulation, elevated serum creatine kinase and rigor.
Storm Christian   +6 more
doaj   +1 more source

Reversible splenial lesion syndrome in neuroleptic malignant syndrome. [PDF]

open access: yes, 2009
Background: Reversible focal lesions in the splenium of the corpus callosum (SCC) or reversible splenial lesion syndrome are rare and little is known about their pathophysiology.
Al-Edrus, Sharifah Aishah   +5 more
core   +1 more source

Propofol-Remifentanil Combination for Management of Electroconvulsive Therapy in a Patient with Neuroleptic Malignant Syndrome

open access: yesCase Reports in Medicine, 2012
Electroconvulsive therapy can be effective in severe or treatment resistant neuroleptic malignant syndrome patients. Anesthesia and use of muscle relaxant agents for electroconvulsive therapy in such patients may encounter anesthesiologists with specific
Modabber Arasteh   +2 more
doaj   +1 more source

Clozapine Induced Neuroleptic Malignant Syndrome [PDF]

open access: yesKorean Journal of Critical Care Medicine, 2017
Neuroleptic malignant syndrome is a rare, but potentially life-threatening adverse event associated with the use of neuroleptic agents. We describe the case of a 47-year-old schizophrenic woman who was treated with clozapine for years.
Yong Suk Jo   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy